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Abstract
Background:  Because prostaglandins are involved in many (patho)physiological processes, SLCO2A1  was already
characterized in several species in an attempt to unravel specific processes/deficiencies. Here, we describe the molecular
cloning and characterization of the porcine ortholog in order to evaluate its possible involvement in F4 enterotoxigenic
E. coli mediated neonatal diarrhoea, based on a positional candidate gene approach study.
Results: Porcine SLCO2A1 is organized in 14 exons, containing an open reading frame of 1935 bp, encoding a 12-
transmembrane organic anion cell surface transporter of 644 aa. The -388 to -5 upstream region comprises a (CpG)48
island containing a number of conserved promoter elements, including a TATA box. A potential alternative promoter
region was found in the conserved -973 to -700 upstream region. No consensus polyadenylation signal was discovered
in the 3' UTR. Repeat sequences were found in 15% of all the non coding sequences.
As expected for a multifunctional protein, a wide tissue distribution was observed. mRNA expression was found in the
adrenal gland, bladder, caecum, colon (centripetal coil/centrifugal coil), diaphragm, duodenum, gallbladder, heart, ileum,
jejunum, kidney, liver, longissimus dorsi muscle, lung, lymph node, mesenterium, rectum, spleen, stomach, tongue and
ureter, but not in the aorta, oesophagus and pancreas.
The promoter region and the exons (including the splice sites) of SLCO2A1 were resequenced in 5 F4ab/ac receptor
positive and 5 F4ab/ac receptor negative pigs. Two silent and 2 missense (both S → L at position 360 and 633) mutations
were found, but none was associated with the F4ab/ac receptor phenotype. In addition, no phenotype associated
differential mRNA expression or alternative/abberant splicing/polyadenylation was found in the jejunum.
Conclusion: The molecular cloning and characterization of porcine SLCO2A1 not only contributes to the already
existing knowledge about the transporter in general, but enables studies on porcine prostaglandin related processes/
deficiencies as patient and/or model. Here we examined its possible involvement as receptor in F4 enterotoxigenic E. coli
mediated neonatal diarrhoea. Because no phenotype associated differences could be found in the gene sequence nor in
its jejunal transcription profile of F4ab/ac receptor positive/negative pigs, SLCO2A1 can most likely be excluded as
receptor for F4 bacteria.
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Background
Prostaglandins are anionic fatty acid derivatives belonging
to the prostanoid subclass of eicosanoids. They are syn-
thesized by all nucleated cells (except lymphocytes) and
act as autocrine/paracrine/endocrine or intracrine signal
molecules by binding to their specific receptors (mostly G
protein-coupled 7-transmembrane receptor family mem-
bers) on the cell surface or nuclear membrane [1,2]. Pros-
taglandins mediate a wide range of (patho)physiological
processes, including reproduction, respiration, cardiovas-
cular homeostasis, intraocular pressure, brain activity,
digestion, renal salt/water transport, bone formation,
immunity, inflammation, tumorigenesis, asthma and
Alzheimer's disease [3-6]. Interfering with prostaglandin
production/action can have important therapeutic impli-
cations, as already shown for the clinical treatment of
glaucoma and impotence, the induction of parturition/
abortion and the provision of gastric protection [7].
Secreted prostaglandins have a short half-life to exert their
function before their reuptake by the cell for inactivation.
Although they can traverse biological membranes by pas-
sive diffusion, efficient efflux and influx is mediated by
specific transporters [8]. The solute carrier organic anion
transporter family, member 2A1 (SLCO2A1, alias PGT) is
involved in both processes [9,10]. SLCO2A1  was first
cloned and characterized in rat [11] and later in man
[7,12], mouse [13], cow [1] and sheep [14] as a single
copy gene encoding a 12-transmembrane organic anion
cell surface transporter with a wide tissue distribution.
In man, SLCO2A1 is examined as a candidate gene for var-
ious diseases [12]. The porcine SLCO2A1 ortholog could
be involved in F4 (alias K88) ETEC mediated neonatal
diarrhoea, a common problem in pig production. F4 bac-
teria use their fimbriae to adhere to specific receptors on
the brush borders of enterocytes of their host. This adhe-
sion is a prerequisite for infection and promotes bacterial
colonization of the small intestine. The colonizing bacte-
ria produce enterotoxins that stimulate the secretion of
water and electrolytes into the lumen of the small intes-
tine and lead to diarrhoea and often death in neonatal
pigs [15]. F4 resistance, acquired by receptor phenotype
differences of the host, seems to be inherited as an auto-
somal recessive Mendelian trait [16]. MUC4  has been
described as a candidate F4ab/ac receptor gene [17]. But
the proposed genotypic F4 resistance associated MUC4
polymorphisms were not associated with total absence of
adhesion of F4 bacteria to the villous brush borders [18],
nor with total absence of diarrhoea [19]. These findings
indicate that there is at least one other F4ab/ac receptor
gene.
The search for such a receptor gene was conducted via the
positional candidate gene approach. A BAC contig on por-
cine chromosome 13 was built by chromosome walking,
covering the region around microsatellite markers Swr926
and Swc22, based on their tight linkage with F4ab/ac
receptor loci [20,21]. One of the annotated genes in the
contig was SLCO2A1, a gene producing several function-
ally distinct mRNAs, by using alternative promoters and/
or splicing [13], and encoding prostaglandin transmem-
brane transporters which contain several different sub-
strate binding sites, to which binding does not always
result in substrate translocation across the membrane [7].
As it is highly expressed on intestinal epithelic cells, where
prostaglandins influence intestinal fluid secretion [22]
and elevated prostaglandin concentrations are shown to
be correlated with diarrhoea [23], porcine SLCO2A1 was
first characterized and then evaluated for its possible
involvement in porcine F4 mediated neonatal diarrhoea.
Results and Discussion
Molecular characterization of porcine SLCO2A1
The porcine SLCO2A1 ORF consists of 1935 bp, encoding
644 aa [GenBank:NM_001123195]. This is as long as its
ortholog in cow, dog and sheep, but 1 aa longer than that
in man, mouse and rat. Sequence comparison shows that
it is most identical with dog (Additional files 1, 2 and 3).
As for the described orthologs, hydropathy and structural
analyses showed that porcine SLCO2A1 contains 7 intra-
cellular, 12 transmembrane and 6 extracellular domains
(Figure 1). The presence of 10% positively and 5% nega-
tively charged aa, makes it a cationic protein (Figure 1).
Amino acid comparison with all the described mammal
sequences shows that 92% of the porcine SLCO2A1 aa are
identical, 4% similar and 4% different (Figure 1, Addi-
tional file 2). The 27 species specific aa are predominantly
seen intracellulary (11/140 aa, of which most in the N-ter-
minal and 4th domain) and extracellulary (13/227 aa,
most of which in the 2nd and 5th domain). Only 3 out of
the 276 transmembrane aa were different (2 in last
domain). The critical prostaglandin binding sites (E78,
A526, A529, C530, H533, R561 and K614; [9,24]), C-C disul-
phide bridges, N-linked glycosylation sites and most of
the S/T/Y kinase phosphorylation sites, all involved in the
transport mechanism and predicted in cow [1] and sheep
[14], were conserved in pig (Figure 1).
Porcine SLCO2A1 is organized in 14 exons, with the start-
codon in the first and the stopcodon in the last exon. All
14 exons and adjacent intergenic/intron regions were
sequenced (15,577 bp in total) [GenBank:DQ104833-
46]. All exons possess consensus donor/acceptor splice
sites and have exactly the same length as their bovine and
canine orthologs. In comparison with the other mammals
there was a maximum of 1 codon difference per exon
(Table 1).
Porcine SLCO2A1 was already mapped to chromosome
13q31-q32 [21], but is not present in the pig genome
sequence (assembly Sscrofa8 v52). However, a BLASTBMC Genetics 2009, 10:64 http://www.biomedcentral.com/1471-2156/10/64
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search in the High Throughput Genomic Sequence data-
base revealed 2 porcine WDSs covering a big part of the
gene. In the [GenBank:CU466981] sequence, containing
16 unordered pieces, homologies were found with exon 1-
2, 4-6 and 10. In the [GenBank:CU633685] sequence,
containing 2 unordered pieces, homologies were found
with exon 5-14 (Figure 2). Because exon 2 and the 3' end
of intron 2 were found in the 7th unordered piece of [Gen-
Bank:CU466981], and the 5' end of intron 3 was found in
the 8th unordered piece, the gap between piece 7 and 8
could be closed with our [GenBank:DQ104835]
sequence, containing exon 3, and the exact length of
intron 2 could be calculated. The 10th unordered piece,
containing exon 1, should be replaced before the joined
pieces 7-8. Because of the gaps, no intron lengths could be
calculated from intron 1 and 3 (estimated in man as 48
and 18 kb resp.; [12]). Since pieces 15 (containing exon 4-
6) and 16 (containing exon 10) of sequence [Gen-
Bank:CU466981] overlap with the first piece of sequence
[GenBank:CU633685] (containing exons 5-10), the gap
between pieces 15 and 16 could be filled and the lengths
of introns 4-9 could be calculated. Exons 11-14 were
found in the 2nd piece of [GenBank:CU466981] and as a
result also the exact intron lengths of introns 11-13 could
be calculated. Both pieces of [GenBank:CU633685] are
correctly ordered and orientated, and the gap between
them, containing a part of intron 10, should be around
100 bp based on the estimated length of intron 10 after
PCR with primers F33/R34 and gelelectrophoresis
(Table 1).
About 1300 bp upstream of the ATG startcodon were
sequenced and compared with the orthologous genomic
sequence in man, mouse, rat and cow (Figure 3). The -388
to -5 region comprises a CpG island with 48 CpGs. It con-
tains a number of conserved promoter elements, such as a
transcription initiation (Inr), TATA box (TBP), Pax-2,
CdxA, RUSH-1α, LRF and Sp1 consensus site and was
Suggested transmembrane model of porcine SLCO2A1 Figure 1
Suggested transmembrane model of porcine SLCO2A1. This model is based on structural and hydropathy analyses of 
the amino acid sequence (as performed on the bovine and ovine orthologs [1,14]) and its homology with the other described 
orthologs (see Additional file 2).
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Table 1: Porcine genomic SLCO2A1 organization
Exon No.
Length (bp)1
Phase
Encoding region2
Mammal length 
differences2
Intron No.
Length (bp)
GenBank
Acc. No.
Repeat sequences Mutations (bp → aa)
1
96
ID1 = 1
NA3
DQ104833 847-916: C-rich
1592-1721: 
(TG)n(GA)n(TG)n
2
138
0
TD1-ED1-TD2
=2
4772
DQ104834 -C 5 9 2 T   → S70L
3
163
0
TD2-ID2-TD3-ED2
=3
NA3
DQ104835 89-109: AT-rich; 153-
201: L1-SS
911-1195: L1 MD
C584A → L84L
4
228
1
ED2-TD4-ID3-TD5
=4
796
DQ104836 -
5
99
1
TD5-ED3
=5
2269
DQ104836 1720-1961: PRE1e
6
137
1
ED3-TD6-ID4
=6
2518
DQ104838 -
7
79
0
ID4
Mouse/Rat: -3 bp = -1 aa 
in I4
Sheep: -3 bp = -1 aa in I4
7
469
DQ104839 -
8
165
1
ID4-TD7-ED4-TD8
=8
1029
DQ104839 1193-1307: MER5B C786T → S360L
9
190
1
TD8-ID5-TD9-ED5
=9
1907
DQ104841 885-1106: PRE1-SS
10
166
2
ED5
Rat: +3 bp = +1 aa in E5 10 ± 24003 DQ104842 36-209: MIRb
11
164
0
ED5-TD10-ID6
Rat: -3 bp = -1 aa in E5
Sheep: +3 bp = +1 aa in 
TM10
11
3481
DQ104843 1-123: CHR-1
12
65
2
ID6-TD11
=1 2
2456
DQ104844 7-169: MER5A
13
124
1
TD11-ED6
=1 3
819
DQ104845 240-342: MIRb
14
121
2
TD12-ID7
Man: -3 bp = -1aa in I7 DQ104846 1211-1334: (CA)n
2099-2294: L3b
A398G → E633E
1CDS in exons; 2ID: intracellular domain, TD: transmembrane domain, ED: extracellular domain; 3NA: not analysed, intron 10 was only estimated 
by measuring the amplification product on an agarose gel.
Schematic representation of the porcine genomic SLCO2A1 organization and its comparison with 2 porcine WDSs Figure 2
Schematic representation of the porcine genomic SLCO2A1 organization and its comparison with 2 porcine 
WDSs.
Sscr13 WDS [GenBank:CU466981]
Sscr13 WDS [GenBank:CU633685]
SscrSLCO2A1promotor and UTR sequence
SscrSLCO2A1 coding sequence
SscrSLCO2A1intron sequence
In silico sequence
Unknown sequence
12 34 5 6 7 8 9 1 0 1 1 1 2 1 3 1 4BMC Genetics 2009, 10:64 http://www.biomedcentral.com/1471-2156/10/64
Page 5 of 9
(page number not for citation purposes)
already described as the promoter region in man [12]. It
also contains a region (-355 to -260) that seems to be spe-
cific for primates (man), rodents (mouse and rat) and
cetartiodactyls (cow and pig). The -700 to -389 region is
less conserved, containing a pig specific insertion (-638
tot -624: AGCACCCCCCCCCCC) and a C-rich region (-
458 to -389). Remarkable is the conservation of the -973
to -700 region. It contains conserved TATA box (TBP),
CdxA, MYB, Pax-2, NF-1, Gfi1, LRF and C-Ets-1(p54) con-
sensus sites, and must be considered as a possible alterna-
tive promoter region. No consensus polyadenylation
signal was discovered in the 3' UTR, as in man [12]. Fif-
teen percent of all the non coding sequences were repeat
sequences, including a
(TG)14(GA)39(GC)2(GA)2(GC)2(GT)2(GC)5-repeat in the
beginning of intron 1 and a CAGA(CA)19C4GCTGCA
GA(CA)9C4GCTGCAGA(CA)21-repeat in the 3' UTR
(Table 1).
Porcine SLCO2A1 transcription profiling
DNA-free RNA was isolated out of 25 different porcine tis-
sues and reverse transcribed into cDNA. PCR was per-
formed with ACTB  and  GAPDH  as positive controls
(Figure 4). ACTB mRNA was present in all tissues except
in the aorta. This is in agreement with the expression data
provided by Unigene, except for the fact that we could
demonstrate  ACTB  mRNA transcription in pancreas.
GAPDH mRNA was present in all tissues except in stom-
ach. In contrast with the data provided by Unigene, we
could not detect GAPDH mRNA in stomach, but we could
detect it in aorta, bladder, oesophagus and pancreas.
These data show that all our samples contain cDNA, but
that care should be taken when using a single reference
gene as positive control in transcription profiling, even for
RT-PCR.
Porcine SLCO2A1 mRNA expression was evaluated in all
25 tissues with 2 different primer pairs, amplifying frag-
ments of resp. exon 3 and 9 (Figure 4). Transcription was
seen in the adrenal gland, bladder, caecum, colon (cen-
tripetal coil/centrifugal coil), diaphragm, duodenum,
gallbladder, heart, ileum, jejunum, kidney, liver, longis-
simus dorsi muscle, lung, lymph node, mesenterium, rec-
tum, spleen, stomach, tongue and ureter. This wide tissue
distribution was expected since prostaglandins mediate a
wide range of (patho)physiological processes and it was
also observed in man, mouse, rat and cow [1,8]. No
SLCO2A1 mRNA was detected in the aorta, oesophagus
and pancreas.
Evaluation of SLCO2A1 involvement in porcine F4 
mediated neonatal diarrhoea
Based on the positional candidate gene approach study by
Van Poucke and co-workers [21] and taking into account
its functional characteristics and its abundant mRNA
expression in the porcine jejunum intestine, SLCO2A1
was evaluated for its possible involvement in porcine F4
mediated neonatal diarrhoea.
A region of 1300 bp upstream of the startcodon, the com-
plete ORF (1935 bp), all splice sites and a region of 1900
bp downstream of the stopcodon were resequenced in 5
F4ab/ac receptor positive and 5 F4ab/ac receptor negative
pigs, all phenotyped via the in vitro villous adhesion test
as described by Rasschaert and co-workers [18], in order
to identify phenotype associated SLCO2A1  polymor-
phisms. As the F4 ab/ac receptor phenotype is monogenic
or oligogenic, it is to be expected of a mutation responsi-
ble for the phenotypes to be present in one group and not
in the other, or at least show a significant distribution dif-
ference that can easily be seen in a small number of ani-
mals. This screening identified 4 SLCO2A1  mutations
(Table 1), 2 silent and 2 missense (both S → L) mutations.
The 2 silent mutations were identified in heterozygous
state in only 1 F4ab/ac receptor positive animal. The 2
missense mutations were exclusively found in hetero-
zygous state in both F4ab/ac receptor positive and F4ab/
ac receptor negative animals. Based on these observations,
it is clear that neither of the polymorphisms is associated
with the F4ab/ac receptor phenotype.
Because of the big phenotype difference between sensitive
or resistant (binding or not), we additionally investigated
the SLCO2A1 mRNA expression in the jejunum of 8 pigs
with a different phenotype (3 strong F4ab/ac receptor pos-
itive, 2 weak F4ab/ac receptor positive and 3 F4ab/ac
receptor negative animals), based on the in vitro villous
adhesion test [18]. The RT-PCR assay was performed with
5 different exon spanning primer pairs covering the whole
SLCO2A1 transcript (except for exon 1) in order to simul-
taneously investigate any alternative/abberant splicing/
polyadenylation. However, all pigs displayed a high
SLCO2A1 mRNA expression in the jejunum and no phe-
notype associated alternative/abberant splicing/polyade-
nylation was observed (Additional file 4).
Conclusion
Because of its role in many (patho)physiological proc-
esses, it is necessary to know the molecular structure of
SLCO2A1 as a basis for unraveling its function. In this
paper we described the molecular structure of the porcine
ortholog. The analysis not only contributes to the already
existing knowledge about SLCO2A1 in general, but can
also be used in the assembly/annotation of the porcine
genome and in future studies on porcine SLCO2A1
related processes/deficiencies as a patient or as a biomed-
ical model [25]. Here we examined its possible involve-
ment in F4 ETEC mediated neonatal diarrhoea, based on
a positional candidate gene approach study. As no pheno-
type associated polymorphisms could be found in theBMC Genetics 2009, 10:64 http://www.biomedcentral.com/1471-2156/10/64
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SLCO2A1 promotor sequence alignment in man (Hsap), mouse (Mmus), rat (Rnor), cow (Btau) and pig (Sscr) Figure 3
SLCO2A1 promotor sequence alignment in man (Hsap), mouse (Mmus), rat (Rnor), cow (Btau) and pig (Sscr). 
Conserved sequences are shaded in black. In silico detected motifs (adescribed by Lu and Schuster [12]; b discovered with Con-
Tra [35]) are indicated in coloured boxes.BMC Genetics 2009, 10:64 http://www.biomedcentral.com/1471-2156/10/64
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promotor region and all exons (including the splice sites)
of SLCO2A1, and no phenotype associated differential
SLCO2A1 mRNA expression or alternative/abberant splic-
ing/polyadenylation could be detected in the porcine jeju-
num, SLCO2A1 can most likely be excluded as receptor
for F4 ETEC.
Methods
Primer design, PCR and sequencing
Primers were designed using Primer3 [26] according to
the acceptable primer design guidelines and selected tak-
ing into account the absence of secondary structures
(mfold, [27]) and repeat sequences (RepeatMasker, [28]).
Primer/amplicon characteristics are listed in Additional
file 5.
Default PCRs were performed in a total volume of 10 μl
on 100 ng genomic DNA, 20 ng BAC DNA or cDNA (an
equivalent of 5 ng RNA) as a template with 500 nM of
each primer, 200 μM of each dNTP, 2 mM MgCl2 and 0.5
U FastStart Taq DNA Polymerase (Roche). Default PCR
programs for PCR amplicons of <500/500><1000/>1000
bp consisted of an initial 4-min denaturation step at
95°C, followed by 30 cycles of 15/30/45 s denaturation at
95°C, 15/30/45 s annealing at 61°C and 30/60/90 s elon-
gation at 72°C, and a final 7-min elongation step at 72°C.
PCR conditions different from default are mentioned in
Additional file 5. Sequencing reactions were performed
with the BigDye Terminator v3.1 Cycle Sequencing Kit
(Applied Biosystems) and after purification with magnetic
beads (Agencourt) analyzed on a 3730xl DNA Analyzer
(Applied Biosystems), according to the manufacturers'
instructions.
Template preparation
Porcine blood collection, storage and DNA isolation was
performed as described by Van Poucke and co-workers
[29]. The screening, annotation and DNA isolation of
BAC clone 884H1 was described by Van Poucke and co-
workers [21]. Fresh samples of 25 different tissues (adre-
nal gland, aorta, bladder, caecum, colon (centripetal coil/
centrifugal coil), diaphragm, duodenum, gallbladder,
heart, ileum, jejunum, kidney, liver, longissimus dorsi
muscle, lung, lymph node, mesenterium, oesophagus,
pancreas, rectum, spleen, stomach, tongue and ureter)
were taken from one pig immediately after slaughtering
and kept in liquid nitrogen. They were subsequently
crushed in a mortar and 100 mg was used to isolate 1-10
μg of total RNA with 1 ml Total RNA Isolation Reaction
(Abgene). Possible traces of genomic DNA were removed
by a RQ1 DNase digest (Promega), followed by a YM-100
microcon purification step (Millipore). This was verified
by a minus RT control using intron-spanning primers of
porcine TOP2B [30]. One μg of DNA-free total RNA was
converted into cDNA by using the iScript cDNA Synthesis
Kit (Bio-Rad). PCRs with primers amplifying ACTB and
GAPDH were used to control for the cDNA synthesis [31].
The jejunum samples of 8 pigs with a different F4ab/ac
receptor phenotype (3 strong F4ab/ac receptor positive, 2
weak F4ab/ac receptor positive and 3 F4ab/ac receptor
negative animals), assessed via the in vitro villous adhe-
sion test [18], were treated in a similar way, except that the
RNA isolation was carried out using the Aurum Total RNA
Fatty and Fibrous Tissue Kit (Bio-Rad) and the cDNA syn-
thesis with the ImProm-II Reverse Transcriptase Kit
(Promega). Experimental procedures and animal manage-
ment procedures were undertaken in accordance with the
requirements of the animal care and ethics committee of
the Faculty of Veterinary Medicine, Ghent University, Bel-
gium (EC2005/65).
Porcine SLCO2A1 sequencing and annotation
Three overlapping porcine SLCO2A1  cDNA amplicons,
covering exon 2 to exon 14, were generated with cDNA
synthesized from RNA isolated from porcine jejunum as a
template, using primers F1/R1-F3/R3 (all based on
human SLCO2A1 [GenBank:U70867] because at the time
of sequencing no porcine genomic sequences were availa-
ble yet) and sequenced with all respective PCR primers as
Transcription profiling of SLCO2A1 in 25 porcine tissues by RT-PCR Figure 4
Transcription profiling of SLCO2A1 in 25 porcine tissues by RT-PCR. ACTB and GAPDH were used as reference genes. 
SLCO2A1 mRNA transcription was analyzed with amplicons from exon 3 and 9.
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sequence primers. The 5' and 3' end of the cDNA was
amplified by using the GeneRacer Kit (Invitrogen). Prim-
ers R4 and R5 were based on the de novo porcine exon 3
SLCO2A1 sequence and used to identify the 5' end of the
porcine  SLCO2A1  transcript. Primers F6 and F7 were
based on an anonymous porcine EST [Gen-
Bank:CF788195], that showed 82% sequence identity
with the 3' UTR of human SLCO2A1, and was used to
identify the 3' end of the porcine SLCO2A1 transcript. The
rest of the sequence was identified by direct sequencing of
porcine BAC 884H1, previously isolated, mapped and
shown to contain SLCO2A1 by Van Poucke and co-work-
ers [21], with primers based on the de novo porcine
SLCO2A1 sequence. The promoter region was sequenced
by primer walking with primers F8 and R9-R11. The gap
between the coding sequence in exon 14 and the 3' end
was filled by primer walking with primers F24-F25 and
R25-R26. All exon-intron bounderies were determined
with primers F1, F8, F13, F15-F23 and R2-R3, R12-R19,
R21, R23. Sequence database searches were performed
with NCBI software (BLAST tool and Nucleotide, Gene
and UniGene databases; [32]), sequence assemblies with
CAP [33], multiple sequence alignments with ClustalW
[34] and the identification of conserved promoter ele-
ments with ConTra [35]. Resequencing of the promoter
region and all exons with splice sites was performed via
direct sequencing of PCR amplicons (with primers F9/R9-
F11/R11, F15/R15, F22/R22 and F24/R24-F36/R36 as
both PCR and sequence primers), generated from
genomic DNA isolated from blood from 5 F4ab/ac recep-
tor positive and 5 F4ab/ac receptor negative pigs, all phe-
notyped via the in vitro villous adhesion test as described
by Rasschaert and co-workers [18].
Porcine SLCO2A1 transcription profiling
Porcine SLCO2A1 mRNA expression was evaluated in all
25 tissues with primers F13/R13 and F19/R19. Potential
differential SLCO2A1 mRNA expression and/or alterna-
tive/abberant splicing/polyadenylation in the jejunum of
8 pigs with a different phenotype (3 strong F4ab/ac recep-
tor positive, 2 weak F4ab/ac receptor positive and 3 F4ab/
ac receptor negative animals), based on the in vitro villous
adhesion test, was investigated by RT-PCR with primers
F18/R18, F26/R26 and F37/R37-F39/R39.
List of abbreviations
aa: amino acids; ACTB: gene encoding actin, beta; BAC:
bacterial artificial chromosome; bp: base pairs; ETEC:
enterotoxigenic Escherichia coli; GAPDH: gene encoding
glyceraldehyde-3-phosphate dehydrogenase; MUC4: gene
encoding mucin 4, cell surface associated; ORF: open
reading frame; RT-PCR: reverse transcription - polymerase
chain reaction; SLCO2A1: gene encoding solute carrier
organic anion transporter family, member 2A1; TOP2B:
gene encoding topoisomerase (DNA) II beta 180 kDa;
UTR: untranslated region; WDS: working draft sequence.
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